Press Releases

Conference Call Scheduled for Thursday, March 8th at 10:00 a.m. Eastern Time

Company invites individual and institutional investors to log-on to view presentation

Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference

MEDFORD, N.Y., Jan. 9, 2012 /PRNewswire/ -- Chembio Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: CEMI) , which develops, manufactures, markets and licenses point-of-care diagnostic tests, today announced that Lawrence A. Siebert, President and Chief Executive Officer, will present at the Biotech

MEDFORD, N.Y., Jan. 3, 2012 /PRNewswire/ -- Chembio Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, is providing this update regarding 2011 developments in the fourth quarter and an updated outlook for 2012.

Conference Call Scheduled for Thursday, November 3, 2011, at 10:00 a.m. Eastern Time

Conference Call Scheduled for Thursday, November 3rd at 10:00 a.m. Eastern Time

Conference Call Scheduled for Thursday, November 3rd At 10:00 a.m. Eastern Time

Chembio's DPP(R) International Patent Protection Expanding MEDFORD, NY, Oct 19, 2011 (MARKETWIRE via COMTEX) -- Chembio Diagnostics, Inc. (OTCQB: CEMI) (PINKSHEETS: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, reported that its Dual Path Platform (DPP ®

Chembio Diagnostics Obtains CE Mark for Its DPP(R) Syphilis Screen & Confirm Assay MEDFORD, NY, Oct 11, 2011 (MARKETWIRE via COMTEX) -- Chembio Diagnostics, Inc. (OTCQB: CEMI) (PINKSHEETS: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announces that its